Boehringer Ingelheim

Berlin Germany Brandenburg Gate

Pharma

Lilly, Boehringer slash investment plans in Germany

In response to a healthcare reform initiative in Germany, Lilly and Boehringer have slashed their planned investments there, each by at least $1B.

Kevin Dunleavy Jun 3, 2026 3:10pm

ASCO exhibit hall entrence

Beaches, birds and more—a tour of ASCO’s exhibit hall floor

Jun 3, 2026 1:28pm

Britain Big Ben United Kingdom London

AbbVie, GSK race up patient reputation leaderboard in the UK

May 22, 2026 9:16am

US Supreme Court

Supreme Court declines to hear IRA challenges from 6 pharmas

May 18, 2026 3:06pm

drug prices biologics drug costs IRA money cash payment co-pay

Top 20 pharma companies by 2025 revenue

Apr 20, 2026 3:00am

Boehringer Ingelheim Boehringer

Boehringer touts promising launches of Hernexeos, Jascayd

Mar 25, 2026 10:57am